Shots:
- Intelligent Bio Solutions has entered into a strategic manufacturing partnership with Syrma Johari MedTech to scale production of its Intelligent Fingerprinting Drug Screening Reader and support long-term margin improvement
- Under the agreement, the partnership advances INBS’ global manufacturing strategy by diversifying suppliers, strengthening supply chain resilience, expanding capacity, and increasing flexibility ahead of anticipated multi-region demand and planned US market entry in 2026
- Syrma Johari plans to open a medical-grade plastics manufacturing facility in India in January 2026, adding capacity and providing an additional manufacturing location in Asia for international clients
Ref: Intelligent Bio Solutions | Image: Intelligent Bio Solutions and Syrma Johari MedTech | Press Release
Related News: Adlai Nortye Licenses AN9025 to ASK Pharm in a ~$230M Deal
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
